Keks N - Search Results

1

No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.

Dean B, Tomaskovic-Crook E, Opeskin K, Keks N, Copolov D. Dean B, et al. Among authors: keks n. Neurochem Int. 1999 Feb;34(2):109-15. doi: 10.1016/s0197-0186(98)00074-6. Neurochem Int. 1999. PMID: 10213068

2

Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients.

Hill C, Keks NA, Jackson H, Kulkarni J, Hannah D, Copolov D, Singh B. Hill C, et al. Among authors: keks na. Aust N Z J Psychiatry. 1992 Sep;26(3):417-22. doi: 10.3109/00048679209072064. Aust N Z J Psychiatry. 1992. PMID: 1358053

3

Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease.

Kulkarni J, Horne M, Butler E, Keks N, Copolov D. Kulkarni J, et al. Among authors: keks n. Biol Psychiatry. 1992 Jun 15;31(12):1225-7. doi: 10.1016/0006-3223(92)90342-w. Biol Psychiatry. 1992. PMID: 1391283 No abstract available.

4

Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.

Keks NA, McKenzie DP, Low LH, McGorry PD, Hill C, Kulkarni J, Singh BS, Copolov DL. Keks NA, et al. Biol Psychiatry. 1992 Sep 1;32(5):426-37. doi: 10.1016/0006-3223(92)90130-r. Biol Psychiatry. 1992. PMID: 1486148

5

The diagnostic validity of paraphrenia.

Hassett AM, Keks NA, Jackson HJ, Copolov DL. Hassett AM, et al. Among authors: keks na. Aust N Z J Psychiatry. 1992 Mar;26(1):18-29. doi: 10.3109/00048679209068306. Aust N Z J Psychiatry. 1992. PMID: 1580882 Review.

6

Comparison of participants and nonparticipants in a neuroendocrine investigation of psychosis.

Keks NA, Copolov DL, Mackie B, Stuart GW, Singh BS, McGorry PD, Coffey C. Keks NA, et al. Acta Psychiatr Scand. 1991 May;83(5):373-6. doi: 10.1111/j.1600-0447.1991.tb05558.x. Acta Psychiatr Scand. 1991. PMID: 1853730

7

Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.

Copolov DL, Keks NA, Kulkarni J, Singh BS, McKenzie D, McGorry P, Hill C. Copolov DL, et al. Among authors: keks na. Psychoneuroendocrinology. 1990;15(3):225-31. doi: 10.1016/0306-4530(90)90033-6. Psychoneuroendocrinology. 1990. PMID: 2255750

8

Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.

Kulkarni J, Keks NA, Stuart G, Mackie B, Minas IH, Singh BS, Copolov DL. Kulkarni J, et al. Among authors: keks na. Acta Psychiatr Scand. 1990 Oct;82(4):271-4. doi: 10.1111/j.1600-0447.1990.tb01383.x. Acta Psychiatr Scand. 1990. PMID: 2260479

9

Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.

Keks NA, Copolov DL, Kulkarni J, Mackie B, Singh BS, McGorry P, Rubin RT, Hassett A, McLaughlin M, van Riel R. Keks NA, et al. Biol Psychiatry. 1990 Jun 1;27(11):1203-15. doi: 10.1016/0006-3223(90)90418-2. Biol Psychiatry. 1990. PMID: 2354227

10

Treatment of schizophrenia.

Keks NA, Kulkarni J, Copolov DL. Keks NA, et al. Med J Aust. 1989 Oct 16;151(8):462-7. doi: 10.5694/j.1326-5377.1989.tb101259.x. Med J Aust. 1989. PMID: 2574412 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters